martes, 23 de agosto de 2011

National Guideline Clearinghouse | ACR Appropriateness Criteria® follow-up of malignant or aggressive musculoskeletal tumors.



full÷text ►
National Guideline Clearinghouse | ACR Appropriateness Criteria® follow-up of malignant or aggressive musculoskeletal tumors.: Guideline Title
ACR Appropriateness Criteria® follow-up of malignant or aggressive musculoskeletal tumors.

Bibliographic Source(s)
Fitzgerald JJ, Roberts CC, Daffner RH, Weissman BN, Appel M, Bancroft L, Bennett DL, Blebea JS, Bruno MA, Fries IB, Germano IM, Hayes CW, Holly L, Kransdorf MJ, Luchs JS, Morrison WB, Olson JJ, Scharf SC, Stoller DW, Taljanovic MS, Tuite MJ, Ward RJ, Wise JN, Zoga AC, Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria® follow-up of malignant or aggressive musculoskeletal tumors. [online publication]. Reston (VA): American College of Radiology (ACR); 2011. 13 p. [55 references]

Guideline Status

This is the current release of the guideline.

This guideline updates a previous version: Roberts CC, Daffner RH, Weissman BN, Bennett DL, Blebea JS, Jacobson JA, Morrison WB, Resnik CS, Rubin DA, Schweitzer ME, Seeger LL, Taljanovic M, Wise JN, Payne WK, Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria® follow-up of malignant or aggressive musculoskeletal tumors. [online publication]. Reston (VA): American College of Radiology (ACR); 2008. 12 p. [54 references]

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

- Enviado mediante la barra Google

No hay comentarios:

Publicar un comentario